BMI Healthcare warns on Competition Commission impact

clock

BMI Healthcare has warned over the potential impact of the Competition Commission's investigation into the UK Private Medical Insurance (PMI) market and said the group will defend its position against any ‘unnecessary or disproportionate remedies.'

The comments came as part of the group's financial results for the year ending 30 September 2013. The figures revealed its EBITDAa from continuing operations was up 14.5% to £56.9 million (FY12: £49.7 million).

Meanwhile, the company saw an overall decline of 1.9% in its caseload compared to the prior year, driven by a fall in PMI volumes, although there had been a slowing rate of decline in the second half of the year. 

The results also anticpated what impact the forthcoming findings and remedies of the Competition Commission, due to be published in 2014, would have on the group.

Stephen Collier, managing director of BMI Healthcare warned: "We continue to assess the potential impact of the proposed remedies which are still in a state of flux and we are very concerned about the significant detrimental impact they could have on patients and healthcare delivery in the UK.

"Accordingly, we continue to engage proactively and openly with the Competition Commission, and where appropriate, have successfully used our rights of appeal to a higher authority."

He again rejected any assertion that BMI Healthcare and its hospitals exercised market power or made excess profits at the expense of patients, as well as describing the Commission's cost analysis as 'flawed.' 

Collier added: "There is significant uncertainty about the eventual findings and any associated remedies and the directors acknowledge that in certain scenarios the potential remedies could have a material impact on the Group.

"Should the final findings fail to appropriately address those flaws then the directors will defend the Group's position against any unnecessary or disproportionate remedies, considering all options available to them."

The firm's statement added that coupled with economic "budgetary constraints", structural uncertainties and continued constraints in the PMI market, the next 12 months are anticipated to "remain challenging for BMI Healthcare."

 

More on PMI

General and Medical Healthcare joins amii
PMI

General and Medical Healthcare joins amii

PMI provider

Jaskeet Briah
clock 04 November 2024 • 1 min read
Benenden Health names Tom Woolgrove as CEO
PMI

Benenden Health names Tom Woolgrove as CEO

Former CII president

Jaskeet Briah
clock 29 October 2024 • 1 min read
Societal ageing and climate change adding to healthcare challenges
PMI

Societal ageing and climate change adding to healthcare challenges

AXA research shows

Jaskeet Briah
clock 14 October 2024 • 2 min read

Highlights

COVER Survey: Advisers damning of protection insurer service levels

COVER Survey: Advisers damning of protection insurer service levels

"It takes longer than ever to get underwriting terms"

John Brazier
clock 12 October 2023 • 5 min read
Online reviews trump price for young people selecting life and health cover

Online reviews trump price for young people selecting life and health cover

According to latest ReMark report

John Brazier
clock 11 October 2023 • 2 min read
ABI members with staff neurodiversity policy nearly doubles

ABI members with staff neurodiversity policy nearly doubles

Women within executive teams have grown to 32%

Jaskeet Briah
clock 10 October 2023 • 3 min read